Year: 2026
Type: article
Abstract: The autophagy-lysosomal pathway constitutes a fundamental intracellular degradation system that recycles cellular components and eliminates damaged organelles through both non-selective and selective mechanisms. Selective autophagy is mediated by specific receptors that target substrates for degradation, including mitochondria (mitophagy), the endoplasmic reticulum (ER-phagy), lipid droplets (lipophagy), and intracellular pathogens (xenophagy), collectively forming a network that maintains cellular homeostasis. In tumors, autophagy-lysosomal dysfunction plays a dual role: on the one hand, it suppresses malignant transformation during early tumorigenesis by maintaining genomic stability and limiting oxidative stress; on the other hand, it drives the progression of established tumors by enhancing metabolic adaptation, promoting therapeutic resistance and facilitating immune evasion. This functional shift is driven by metabolic reprogramming within the tumor microenvironment, ferroptosis inhibition, inflammasome activation and spatiotemporal heterogeneity. Recent therapeutic strategies have evolved from broad-spectrum inhibitors toward precision interventions, including nanodrug delivery systems, patient stratification guided by single-cell and spatial multi-omics and targeted protein degradation. Technologies such as proteolysis-targeting chimeras and lysosome-targeting chimeras offer promising approaches for selectively modulating protein degradation pathways. The integration of these approaches with immune checkpoint blockade and epigenetic modulators has opened new avenues for overcoming drug resistance and improving clinical outcomes. This review systematically explores the molecular mechanisms, dual functions and therapeutic implications of autophagy-lysosomal dysfunction in cancer, emphasizing the shift from non-selective inhibition toward selective precision targeting.
Source: Theoretical and Natural Science
Author: Yuming Lou
Institution: Chongqing Medical University
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Keywords: autophagy-lysosome pathway, selective autophagy, mitophagy, ER-phagy, lipophagy, xenophagy, tumor metabolic reprogramming, tumor microenvironment, treatment resistance, immune evasion, ferroptosis, inflammasome, tumor heterogeneity, PROTACs, lysosome-targeting chimeras, targeted protein degradation, immune checkpoint blockade, epigenetic modulation, cancer therapy
Open Access status: hybrid
OpenAlex ID: W7235077244
